Jeff Yass’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAC
6CM
Jeff Yass's RNAC Position: Q3 2026 in Review
Jeff Yass opened a new position in Cartesian Therapeutics (RNAC) in Q3 2026: 27,007 shares worth $195K. The stake represents ﹤0.01% of the portfolio and ranks #12002 among its holdings. This is a return to the name: Jeff Yass previously reported a position in RNAC as recently as Q3 2025.
Jeff Yass first reported a position in RNAC in Q1 2017 and has held it in 22 quarters since. The position peaked at $1.17M in Q1 2023. 95 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.
- Jeff Yass held 27,007 shares of Cartesian Therapeutics worth $195K as of Q3 2026.
- Cartesian Therapeutics was a new Jeff Yass position in Q3 2026.
- Cartesian Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12002 holding.
- Jeff Yass first reported a position in Cartesian Therapeutics in Q1 2017 and has held it in 22 quarters since.
- Jeff Yass's Cartesian Therapeutics position peaked at $1.17M in Q1 2023.
- 95 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.